Evox Therapeutics is Biotechnology in United Kingdom that focus on therapeutics use business. Founded in 2016. They cover business area such as developer, exosome-base therapeutic, various severe disease, profound implication, human health, nucleic acid and protein delivery technology, extracellular vesicle, healthcare provider, proprietary targeting, manufacturing process, purification method.
2016
( 8 years old in 2024 )
Therapeutics Use
-
Oxford Science Park, Medawar Centre
2nd Floor East Building, Robert Robinson Avenue
Oxford OX4 4HG
England, United Kingdom
Private
developerexosome-base therapeuticvarious severe diseaseprofound implicationhuman healthnucleic acid and protein delivery technologyextracellular vesiclehealthcare providerproprietary targetingmanufacturing processpurification method
* We use standard office opening hours in near Evox Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Evox Therapeutics is Biotechnology business from United Kingdom that founded in 2016 (8 years old in 2024), Evox Therapeutics business is focusing on Therapeutics Use.
Evox Therapeutics headquarter office and corporate office address is located in Oxford Science Park, Medawar Centre 2nd Floor East Building, Robert Robinson Avenue Oxford OX4 4HG England, United Kingdom.
Evox Therapeutics was founded in United Kingdom.
In 2024, Evox Therapeutics is currently focus on therapeutics use sector.
Above is snippet of Google Trends for "therapeutics use" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Evox Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.